Opko Health, Inc. Share Price Today: Live Updates & Key Insights

Opko Health, Inc. share price today is $1.14, up -4.27%. The stock opened at $1.16 against the previous close of $1.17, with an intraday high of $1.17 and low of $1.1.

Opko Health, Inc. Share Price Chart

Opko Health, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Opko Health, Inc. Share Price Performance

$1.14 -0.0427(-4.27%) OPK at 23 Mar 2026 02:37 PM Diagnostics & Research
Lowest Today 1.1
Highest Today 1.17
Today’s Open 1.16
Prev. Close 1.17
52 Week High 1.83
52 Week Low 1.10
Day’s Range: Low 1.1 High 1.17
52-Week Range: Low 1.10 High 1.83
1 day return -
1 Week return -6.69
1 month return -3.04
3 month return -15.84
6 month return -22.29
1 year return -38.05
3 year return -14.88
5 year return -77.42
10 year return -

Opko Health, Inc. Institutional Holdings

Rubric Capital Management LP 6.30

BlackRock Inc 4.37

Vanguard Group Inc 4.28

Geode Capital Management, LLC 1.46

iShares Russell 2000 ETF 1.31

Vanguard Total Stock Mkt Idx Inv 1.24

State Street Corp 1.19

Vanguard Small Cap Index 0.92

UBS Group AG 0.63

Vanguard Institutional Extnd Mkt Idx Tr 0.62

Whitefort Capital Management, LP. 0.56

Fidelity Small Cap Index 0.53

Charles Schwab Investment Management Inc 0.49

Northern Trust Corp 0.48

iShares Russell 2000 Value ETF 0.46

iShares Biotechnology ETF 0.39

Citadel Advisors Llc 0.38

The Goldman Sachs Group Inc 0.31

Fidelity Extended Market Index 0.30

Vanguard Small Cap Value Index Inv 0.29

Awm Investment Company Inc 0.28

Schwab US Small-Cap ETF™ 0.27

AQR Capital Management LLC 0.27

Vanguard Russell 2000 ETF 0.26

Vanguard Small Cap Growth Index Inv 0.25

State St Russell Sm/Mid Cp® Indx SL Cl I 0.25

Jane Street Group LLC 0.23

Dimensional Fund Advisors, Inc. 0.21

WASHINGTON GROWTH STRATEGIES LLC 0.18

PFG Investments, LLC 0.17

Bank of America Corp 0.17

Y.D. More Investments Ltd 0.17

Vanguard Health Care ETF 0.17

Bank of New York Mellon Corp 0.17

Invesco S&P 500 ETF 0.17

State St Russell Sm Cap® Indx SL Cl I 0.16

Blackrock Extended Mkt Fund CF 0.14

Schwab Small Cap Index 0.14

Extended Equity Market Fund K 0.12

NT R2000 Index Fund - NL 0.12

Opko Health, Inc. Market Status

Strong Buy: 2

Buy: 4

Hold: 1

Sell: 0

Strong Sell: 0

Opko Health, Inc. Fundamentals

Market Cap 859.83 M

PB Ratio 0.6645

PE Ratio 0.0

Enterprise Value 870.27 M

Total Assets 1931.94 M

Volume 4522222

Opko Health, Inc. Company Financials

Annual Revenue FY23:866931000 866.9M, FY22:1004200000 1004.2M, FY21:1774700000 1774.7M, FY20:1435400000 1435.4M, FY19:901900000 901.9M

Annual Profit FY23:329414000 329.4M, FY22:288200000 288.2M, FY21:581500000 581.5M, FY20:541000000 541.0M, FY19:329400000 329.4M

Annual Net worth FY23:-207611000 -207.6M, FY22:-328000000 -328.0M, FY21:-29500000 -29.5M, FY20:30600000 30.6M, FY19:-312000000 -312.0M

Quarterly Revenue Q3/2025:151669000 151.7M, Q2/2025:156807000 156.8M, Q1/2025:149952000 150.0M, Q3/2024:173632000 173.6M, Q2/2024:182186000 182.2M

Quarterly Profit Q3/2025:71267000 71.3M, Q2/2025:49402000 49.4M, Q1/2025:42620000 42.6M, Q3/2024:40129000 40.1M, Q2/2024:31233000 31.2M

Quarterly Net worth Q3/2025:21631000 21.6M, Q2/2025:-148441000 -148.4M, Q1/2025:-67613000 -67.6M, Q3/2024:24890000 24.9M, Q2/2024:-10305000 -10.3M

About Opko Health, Inc. & investment objective

Company Information OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.

Organisation Diagnostics & Research

Employees 2275

Industry Diagnostics & Research

CEO Dr. Phillip Frost M.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Opko Health, Inc. FAQs

What is the share price of Opko Health, Inc. today?

The current share price of Opko Health, Inc. is $1.14.

Can I buy Opko Health, Inc. shares in India?

Yes, Indian investors can buy Opko Health, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Opko Health, Inc. shares in India?

You can easily invest in Opko Health, Inc. shares from India by:

Can I buy fractional shares of Opko Health, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Opko Health, Inc.?

Opko Health, Inc. has a market cap of $859.83 M.

In which sector does Opko Health, Inc. belong?

Opko Health, Inc. operates in the Diagnostics & Research sector.

What documents are required to invest in Opko Health, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Opko Health, Inc.?

The PE ratio of Opko Health, Inc. is N/A and the PB ratio is 0.66.